Connect with others who understand.

Sign up Log in
Resources
About MyMSTeam
Powered By
See answer

What Are S1P Receptor Modulators?

Medically reviewed by Evelyn O. Berman, M.D.
Written by Brooke Dulka, Ph.D.
Posted on July 23, 2021

  • Sphingosine-1-phosphate (S1P) receptor modulators are a newer class of disease-modifying therapies that can be used to treat relapsing forms of multiple sclerosis (MS).
  • S1P receptor modulators are taken orally once or twice a day.
  • S1P receptor modulators are believed to work by reducing the activity of immune cells in the brain and spinal cord.

Although multiple sclerosis cannot yet be cured, there are medications that can slow its progression and reduce symptoms. In recent years, a newer class of disease-modifying therapy (DMT) known as sphingosine-1-phosphate receptor modulators have been approved to treat relapsing forms of MS.

S1P receptor modulators are drugs that help regulate the immune system. S1P receptor modulators are believed to work by blocking the S1P receptors found on the surface of lymphocytes — a type of white blood cell — that contribute to MS attacks. Generally, S1P receptor modulators are oral medications taken once or twice daily.

How Do S1P Receptor Modulators Work?

Receptors are like the “locks” on cells within the body, and antagonist drugs can function like “keys” to open them. S1P receptor modulators are believed to work via indirect antagonism of the S1P receptor.

An antagonist is a drug that reduces activity at a given receptor site. S1P receptor modulators are indirect antagonists because they don’t work on the receptor site directly, but bind to a different target that influences the S1P receptors’ activity.

The effect of S1P receptor modulators is to trap lymphocytes within the lymph nodes, away from the brain and spinal cord — also called the central nervous system or CNS. If lymphocytes can’t enter the CNS, they can’t contribute to MS attacks. There are several subtypes of S1P receptors, and each of the currently available S1P receptor modulators acts on the receptor subtypes differently. This leads to specific effects from each S1P receptor antagonist drug, making some S1P receptor modulators better options for one type of MS over another type.

What S1P Receptor Modulators Are Currently Available?

There are now several S1P receptor modulators approved to treat MS. These drugs include Gilenya (fingolimod), Mayzent (siponimod), Ponvory (ponesimod), and Zeposia (ozanimod).

S1P Receptor Modulators for Relapsing Forms of MS
Approved To Treat

Gilenya

(fingolimod)

Mayzent

(siponimod)

Ponvory

(ponesimod)

Zeposia

(ozanimod)

Clinically isolated syndrome (CIS)XXXX
Relapsing-remitting MS (RMSS)XXXX
Active secondary progressive MS (SPMS)XXXX
SourcesReferenceReferenceReferenceReference

When Are S1P Receptor Modulators Prescribed?

These drugs are typically used for the treatment of various types of MS, which include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. These forms of MS may be characterized by attacks (or relapses) of new or increasing neurological symptoms. CIS can progress to RRMS, and RRMS can likewise progress to SPMS. Unless treated with DMTs, MS progression can lead to increases in disability and reduced quality of life.

Learn more about relapsing forms of MS.

According to the Consortium of Multiple Sclerosis Centers, any approved drug for MS can be prescribed as a first-line treatment for relapsing forms of MS. However, S1P receptor modulators are more likely to be prescribed for relapsing MS that seems to be progressing. This is because of the S1P receptor modulators’ mechanism of action. Specifically, by preventing lymphocytes from entering the central nervous system, MS progression can be slowed. This has been scientifically shown in phase 3 clinical trials of S1P drugs such as Mayzent, where a significant reduction in disability progression was observed compared to placebo.

Remember, although there is no cure for MS, DMTs are proven to slow MS disease progression. People with MS can live with an improved quality of life with DMTs, including S1P receptor modulators.

Read more about what to expect when starting an S1P receptor modulator.

Talk With Others Who Understand

MyMSTeam is the social network for people with multiple sclerosis and their loved ones. On MyMSTeam, more than 170,000 members come together to ask questions, give advice, and share their stories with others who understand life with multiple sclerosis.

Are you living with multiple sclerosis? Have you taken an S1P receptor modulator for your MS? Share your experience in the comments below, or start a conversation by posting on your Activities page.

Posted on July 23, 2021

A MyMSTeam Member

one man's trash is another man's treasure. it worked wonderfully for me fr many years

July 12, 2022
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Brooke Dulka, Ph.D. is a freelance science writer and editor. She received her doctoral training in biological psychology at the University of Tennessee. Learn more about her here.

Related Articles

Five disease-modifying therapies (DMTs) given by intravenous infusion are approved to treat mult...

8 Facts About MS Infusion Treatments: Risks and Benefits

Five disease-modifying therapies (DMTs) given by intravenous infusion are approved to treat mult...
Talking about how multiple sclerosis (MS) can affect sexual function and desire can be difficult....

Can MS Cause Hypersexuality?

Talking about how multiple sclerosis (MS) can affect sexual function and desire can be difficult....
People with multiple sclerosis (MS) are at a higher risk of weight gain.Managing a healthy weight...

Can MS Cause Weight Change? 4 Tips for Maintaining a Healthy Weight

People with multiple sclerosis (MS) are at a higher risk of weight gain.Managing a healthy weight...
Disease-modifying therapies (DMTs) can be effective treatment for multiple sclerosis (MS). These ...

DMTs for MS: 3 Signs It Might Be Time To Switch and What To Know

Disease-modifying therapies (DMTs) can be effective treatment for multiple sclerosis (MS). These ...
Certain disease-modifying treatments (DMTs) for multiple sclerosis (MS) have been classified as...

What Are the Most Effective Treatments for MS? Know Your DMTs

Certain disease-modifying treatments (DMTs) for multiple sclerosis (MS) have been classified as...
Diphenhydramine — sold under many brand names including Benadryl — is a type of antihistamine tha...

Why Is Benadryl Given With Some MS Treatments?

Diphenhydramine — sold under many brand names including Benadryl — is a type of antihistamine tha...

Recent Articles

Multiple sclerosis is not hereditary, but it does occur within families. Click to learn more!

Is MS Inherited From Your Mother or Father? 5 Factors That Matter (VIDEO)

Multiple sclerosis is not hereditary, but it does occur within families. Click to learn more!
Although scientists don’t fully understand what causes multiple sclerosis (MS), they believe that...

Genetic Factors in MS: HLA-DRB1 and More (VIDEO)

Although scientists don’t fully understand what causes multiple sclerosis (MS), they believe that...
Scientists have proposed different ideas about why autoimmune diseases such as multiple sclerosis...

Multiple Sclerosis in Men vs. Women: 5 Symptom Differences and More

Scientists have proposed different ideas about why autoimmune diseases such as multiple sclerosis...
Multiple sclerosis (MS) does not affect everyone at equal rates. Some people are more likely than...

Who Gets MS? Prevalence, Epidemiology, and More

Multiple sclerosis (MS) does not affect everyone at equal rates. Some people are more likely than...
Multiple sclerosis (MS) is a chronic, immune-mediated disorder that affects around 1 million peop...

How Many People Live With MS? (VIDEO)

Multiple sclerosis (MS) is a chronic, immune-mediated disorder that affects around 1 million peop...
Five disease-modifying therapies (DMTs) approved by the U.S. Food and Drug Administration (FDA) ...

Schedules for MS Infusions: Monthly, Twice a Year, and Other Frequencies

Five disease-modifying therapies (DMTs) approved by the U.S. Food and Drug Administration (FDA) ...

Thank you for subscribing!

Become a member to get even more: